PeterT.PistersMD

General Surgery • Houston, TX

Surgical Oncology (Other than Breast)

Professor of Surgery, University Tex Houston

Join to view full profile

Dr. Pisters is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Pisters' full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6000
Is this information wrong?

Education & Training

Harvard School of Public HealthMS, Healthcare Management, 2012 - 2014
NYU Grossman School of MedicineResidency, Surgery, 1985 - 1992
University of Western OntarioClass of 1985

Certifications & Licensure

TX State Medical License 1994 - 2026
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors:SE Texas Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Fellow American College of Surgeons
Join now to see all

Clinical Trials

Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 1998 Mar 01
Completed
Phase 1
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma Start of enrollment: 1997 Jul 01
Completed
Phase 1
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Withdrawn
Phase 2
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer Start of enrollment: 2002 May 01
Completed
Phase 2
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Start of enrollment: 2004 Aug 01
Completed
Phase 3
Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma Start of enrollment: 2003 Jan 01
Completed
Phase 1
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
Completed
Phase 2
PP-Gemcitabine & External Beam Radiation-Sarcomas Start of enrollment: 2001 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume.
Kevin J Contrera, Samantha Tam, Kristen Pytynia, Eduardo M Diaz Jr, Amy C Hessel, Ryan P Goepfert, Miriam Lango, Shirley Y Su, Jeffrey N Myers, Randal S Weber, Arturo ...> ;Annals of Surgical Oncology. 2023 Apr 1
1 citations
Impact of Cancer Care Regionalization on Patient Volume.
Kevin J Contrera, Samantha Tam, Kristen Pytynia, Eduardo M Diaz Jr, Amy C Hessel, Ryan P Goepfert, Miriam Lango, Shirley Y Su, Jeffrey N Myers, Randal S Weber, Arturo ...> ;Annals of Surgical Oncology. 2023 Apr 1
A flexible-hazards cure model with application to patients with soft tissue sarcoma.
Can Xie, Xuelin Huang, Ruosha Li, Peter W T Pisters> ;Statistics in Medicine. 2022 Dec 20
2 citations
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Tria...
Waddah B. Al-Refaie, Paul A. Decker, Karla V. Ballman, Peter W.T. Pisters, Mitchell C. Posner, Kelly K. Hunt, Bryan F. Meyers, Armin D. Weinberg, Heidi Nelson, Lisa A....> ;Annals of Surgical Oncology. 2019 Oct 11
18 citations
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial.
Alice C. Wei, Fang-Shu Ou, Qian Shi, Xiomara W. Carrero, Eileen M. O'Reilly, Jeffrey A. Meyerhardt, Robert A. Wolff, Hedy L. Kindler, Douglas B. Evans, Vikram Deshpand...> ;Annals of Surgical Oncology. 2019 Dec 1
106 citations
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
Jordan M. Cloyd, Matthew H.G. Katz, Laura R. Prakash, Gauri R. Varadhachary, Robert A. Wolff, Rachna T. Shroff, Milind Javle, David R. Fogelman, Michael J. Overman, Ch...> ;Journal of Gastrointestinal Surgery. 2017 Jan 1
6 citations
A Bayesian multivariate joint frailty model for disease recurrences and survival
Sijin Wen, Xuelin Huang, Ralph F. Frankowski, Janice N. Cormier, Peter W.T. Pisters> ;Statistics in Medicine. 2016 Nov 20
725 citations
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial
James W. Fleshman, Megan E. Branda, Daniel J. Sargent, Anne Marie Boller, Virgilio George, Maher A. Abbas, Walter R. Peters, Dipen Maun, George J. Chang, Alan J. Herli...> ;JAMA. 2015 Oct 6
46 citations
Superior mesenteric artery margin of posttherapy pancreaticoduodenectomy and prognosis in patients with pancreatic ductal adenocarcinoma
Li Liu, Matthew H.G. Katz, Sun M. Lee, Laurice K. Fischer, Laura R. Prakash, Nathan H. Parker, Hua Wang, Gauri R. Varadhachary, Robert A. Wolff, Jeffrey E. Lee, Peter ...> ;The American Journal of Surgical Pathology. 2015 Oct 1
6 citations
Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.
Mitri Khoury, Geok Choo Sim, Michiko Harao, Laszlo Radvanyi, Behrang Amini, Robert S. Benjamin, Peter W.T. Pisters, Raphael E. Pollock, William W. Tseng> ;BMJ Case Reports. 2015 Jul 8
93 citations
Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer
Christina L. Roland, Anthony D. Yang, Matthew H.G. Katz, Deyali Chatterjee, Huamin Wang, Heather Lin, Jean Nicholas Vauthey, Peter W.T. Pisters, Gauri R. Varadhachary,...> ;Annals of Surgical Oncology. 2015 Mar 1
207 citations
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
Christopher L. Corless, Karla V. Ballman, Cristina R. Antonescu, Violetta Kolesnikova, Robert G. Maki, Peter W.T. Pisters, Martin E. Blackstein, Charles D. Blanke, Geo...> ;Journal of Clinical Oncology. 2014 May 20
131 citations
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.
Ching Wei D. Tzeng, Aparna Balachandran, Mediha Ahmad, Jeffrey E. Lee, Sunil Krishnan, Huamin Wang, Christopher H. Crane, Robert A. Wolff, Gauri R. Varadhachary, Peter...> ;HPB. 2014 May 1
86 citations
Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection?
William W. Tseng, John E. Madewell, Wei Wei, Neeta Somaiah, Alexander J. Lazar, Markus P. Ghadimi, Aviad Hoffman, Peter W.T. Pisters, Dina Lev, Raphael E. Pollock> ;Annals of Surgical Oncology. 2014 Apr 7
32 citations
Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients.
Ching Wei D. Tzeng, Matthew H.G. Katz, Jeffrey E. Lee, Jason B. Fleming, Peter W.T. Pisters, Jean Nicolas Vauthey, Thomas A. Aloia> ;HPB. 2014 Apr 1
24 citations
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.
Brian K. Bednarski, Dejka M. Araujo, Min Yi, Keila E. Torres, Alexander J. Lazar, Jonathan C. Trent, Janice N. Cormier, Peter W.T. Pisters, Dina Lev, Raphael E. Polloc...> ;Annals of Surgical Oncology. 2014 Mar 18
38 citations
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification.
Ching Wei D. Tzeng, Matthew H.G. Katz, Jason B. Fleming, Jeffrey E. Lee, Peter W.T. Pisters, Holly M. Holmes, Gauri R. Varadhachary, Robert A. Wolff, James L. Abbruzze...> ;Journal of Gastrointestinal Surgery. 2014 Jan 1
151 citations
Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival
Ching Wei D. Tzeng, Hop S. Tran Cao, Jeffrey E. Lee, Peter W.T. Pisters, Gauri R. Varadhachary, Robert A. Wolff, James L. Abbruzzese, Christopher H. Crane, Douglas B. ...> ;Journal of Gastrointestinal Surgery. 2014 Jan 1
28 citations
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenoca...
Deyali Chatterjee, Matthew H.G. Katz, Asif Rashid, Jeannelyn S. Estrella, Hua Wang, Gauri R. Varadhachary, Robert A. Wolff, Jeffrey E. Lee, Peter W.T. Pisters, James L...> ;Histopathology. 2013 Dec 1
79 citations
Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer
Hop S. Tran Cao, Alpana Balachandran, Huamin Wang, Graciela M. Nogueras-Gonzalez, Christina E. Bailey, Jeffrey E. Lee, Peter W.T. Pisters, Douglas B. Evans, Gauri R. V...> ;Journal of Gastrointestinal Surgery. 2014 Feb 1
2 citations
Quality Assessment Across A National Cancer Network
William J. Simeone, John Bingham, Thomas W. Burke, Peter W.T. Pisters> ;Journal of Oncology Practice. 2013 May 1
106 citations
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, Christopher L. Corless, Violetta Kolesnikova, Margaret von Mehren, Martin D. McCarter, Jeffrey A. Norton, ...> ;Annals of Surgery. 2013 Sep 1
22 citations
Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma
Wai Chin Foo, Asif Rashid, Hua Wang, Matthew H.G. Katz, Jeffrey E. Lee, Peter W.T. Pisters, Robert A. Wolff, James L. Abbruzzese, Jason B. Fleming, Huamin Wang> ;Human Pathology. 2013 Jun 1
249 citations
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
Matthew H.G. Katz, Robert W. Marsh, Joseph M. Herman, Qian Shi, Eric Collison, Alan P. Venook, Hedy L. Kindler, Steven R. Alberts, Philip A. Philip, Andrew M. Lowy, Pe...> ;Annals of Surgical Oncology. 2013 Feb 23
51 citations
Frequency and Intensity of Postoperative Surveillance After Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis
Ching Wei D. Tzeng, Daniel E. Abbott, Scott B. Cantor, Jason B. Fleming, Jeffrey E. Lee, Peter W.T. Pisters, Gauri R. Varadhachary, James L. Abbruzzese, Robert A. Wolf...> ;Annals of Surgical Oncology. 2013 Feb 14
Join now to see all

Press Mentions

MD Anderson Receives Nearly $19.4 Million in CPRIT FundingFebruary 14th, 2023
MD Anderson Names Dr. Donna Hansel Division Head of Pathology and Lab MedicineJuly 18th, 2022
MD Anderson Unveils New Cancer Research CenterJune 7th, 2022
Join now to see all